BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9591955)

  • 1. Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study.
    Konstas AG; Tsatsos I; Kardasopoulos A; Bufidis T; Maskaleris G
    Acta Ophthalmol Scand; 1998 Apr; 76(2):208-12. PubMed ID: 9591955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma.
    Konstas AG; Mantziris DA; Stewart WC
    Arch Ophthalmol; 1997 Feb; 115(2):182-5. PubMed ID: 9046252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.
    Konstas AG; Mantziris DA; Cate EA; Stewart WC
    Arch Ophthalmol; 1997 Aug; 115(8):975-9. PubMed ID: 9258218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma.
    Rekonen P; Kannisto T; Puustjärvi T; Teräsvirta M; Uusitalo H
    Acta Ophthalmol Scand; 2006 Aug; 84(4):507-11. PubMed ID: 16879572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
    Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
    Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
    Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M
    Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sclerectomy in primary open-angle glaucoma and exfoliative glaucoma.
    Suominen SM; Harju MP; Vesti ET
    Eur J Ophthalmol; 2016 Nov; 26(6):568-574. PubMed ID: 26951530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 24 hour control with Timoptic 0.5% and Timoptic-XE 0.5% in exfoliation and primary open-angle glaucoma.
    Konstas AG; Mantziris DA; Maltezos A; Cate EA; Stewart WC
    Acta Ophthalmol Scand; 1999 Oct; 77(5):541-3. PubMed ID: 10551296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of primary open-angle glaucoma and exfoliation glaucoma at diagnosis.
    Tarkkanen AH; Kivelä TT
    Eur J Ophthalmol; 2015; 25(2):137-9. PubMed ID: 25198170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Hypertonic Saline to Lower Intraocular Pressure in Ocular Hypertension and Primary Open-angle and Exfoliation Glaucoma.
    Inborr PK; Harju M; Kivelä TT
    J Glaucoma; 2018 Jul; 27(7):638-642. PubMed ID: 29750719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients.
    Beyazyıldız E; Beyazyıldız O; Arifoğlu HB; Altıntaş AK; Köklü SG
    Indian J Ophthalmol; 2014 Jul; 62(7):782-7. PubMed ID: 25116770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma.
    Ting JL; Damji KF; Stiles MC;
    J Cataract Refract Surg; 2012 Feb; 38(2):315-23. PubMed ID: 22322166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phacoviscocanalostomy in pseudoexfoliation glaucoma versus primary open-angle glaucoma.
    Awadalla MA; Hassan KM
    Can J Ophthalmol; 2011 Feb; 46(1):77-82. PubMed ID: 21283163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified goniotomy as an alternative to trabectome in primary open angle glaucoma and pseudoexfoliation glaucoma: 1 year results.
    Pahlitzsch M; Gonnermann J; Maier AB; Bertelmann E; Klamann MK; Erb C
    Can J Ophthalmol; 2017 Feb; 52(1):92-98. PubMed ID: 28237157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma.
    Hengerer FH; Auffarth GU; Yildirim TM; Conrad-Hengerer I
    BMC Ophthalmol; 2018 Dec; 18(1):339. PubMed ID: 30587169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.
    Rönkkö S; Rekonen P; Kaarniranta K; Puustjärvi T; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):697-704. PubMed ID: 17028863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
    Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
    Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal viscoelastic differences between pseudoexfoliative glaucoma and primary open-angle glaucoma.
    Ozkok A; Tamcelik N; Ozdamar A; Sarici AM; Cicik E
    J Glaucoma; 2013 Dec; 22(9):740-5. PubMed ID: 24299728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of 180 degrees of treatment with diode laser trabeculoplasty in primary open-angle glaucoma and exfoliation glaucoma: a short-term study of 22 patients.
    Andreić V; Miljković A; Babić N
    Curr Eye Res; 2009 Mar; 34(3):202-6. PubMed ID: 19274527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary open-angle glaucoma in a population associated with high prevalence of primary angle-closure glaucoma: the Kumejima Study.
    Yamamoto S; Sawaguchi S; Iwase A; Yamamoto T; Abe H; Tomita G; Tomidokoro A; Araie M
    Ophthalmology; 2014 Aug; 121(8):1558-65. PubMed ID: 24746386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.